Coston McIsaac & Partners’s Solventum SOLV Stock Holding History
Bought
Maintained
Sold
Other funds holding SOLV
IFP
TFM
DSA
Coston McIsaac & Partners's SOLV Position: Q2 2026 in Review
Coston McIsaac & Partners increased its Solventum (SOLV) stake by 1% in Q2 2026, buying an estimated $73 and bringing the position to 98 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #646.
Coston McIsaac & Partners first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $10K in Q2 2025. 883 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.
- Coston McIsaac & Partners held 98 shares of Solventum worth $7K as of Q2 2026.
- Coston McIsaac & Partners bought 1 Solventum share in Q2 2026, an estimated $73.
- Solventum made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #646 holding.
- Coston McIsaac & Partners first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
- Coston McIsaac & Partners's Solventum position peaked at $10K in Q2 2025.
- 883 funds tracked by Wall St. Rank held Solventum as of Q2 2026.
Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.